Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Prurisol ph2b psoriasis trial results need to come out before you can count it's value in a buyout.

If good, having two drugs (Brilacidin and Prurisol) proven in completed ph 2's gives more value than just a single drug.

Kevetrin is a bit of a crap shoot as far as anyone paying a decent amount for it at this point in time. But, I haven't a clue as to whom Leo is talking to about it. Some entities will give it more potential value than others.

Bottom line, none of us know what to expect at this time in terms of dollars. I'm still holding since I believe there is a reasonable chance of Leo putting a deal together in the very near future. I just don't look for the high numbers that you expect. Hopefully, you are correct. ;)







In Reply to 'petemantx'
How many biotech companies have 3 drugs at the same time finished w/ Phase 2 trials?

Add in that all 3 appear safe beyond a doubt and address massive multiple markets?

If you don't think our drugs are disruptive your query is valid, if you think we have cutting edge science that will address lots of problems resulting in massive revenues, then your query is invalid.

I am on the side of disruptive.